
    
      An interventional, randomized, double-blind, placebo-controlled study will be conducted to
      investigate the effect of a new probiotic strains Lactobacillus PS11603 & Bifidobacterium
      PS10402 in 30 premature infants born within 28 weeks + 0 days to 30 weeks + 6 days of
      gestation.

      The duration of participation in the study is estimated to be 40-60 days. Participants will
      be randomized assigned to one of the two arms of the study: the control group, with placebo
      consumption, and a probiotic consumption group. The aim of the study will be investigate the
      effect of the probiotics strains in the colonization of the intestinal tract of preterm
      babies.
    
  